Insider trades

Andrew R. Allen, Director of Cullinan Therapeutics CGEM, has filed 0 purchases and 1 sale on the open market. The latest trade was on 06/16.

Andrew R. Allen

Director
First filing
23/02/06
Trades
24 trades
Buys / sales
0 / 1
12-month net buying
No record
Last trade
06/16

Trading activity

Transactions

Trade type
Open-market sale24/05/1624/05/1724,263 sh$0.75$18,197.25−2.4%